Quest Diagnostics Inc (DGX) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Quest Diagnostics Inc  (NYSE: DGX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Quest Diagnostics Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Quest Diagnostics Inc's ROI in the third quarter of 2026?
Quest Diagnostics Inc achieved a return on average invested assets (ROI) of 8.32 % in its third quarter of 2026, which is below Quest Diagnostics Inc's average return on investment, which stands at 9.49%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 61 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1016, from total ROI ranking in the second quarter of 2026 at 1192.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 11.05 % 5.22 % 3.88 % 9.65 % 13.94 %
Y / Y Net Income Change TTM 13.65 % 10.86 % 51.84 % 121.14 % 332.91 %
Investment (TTM) in Millions 15,468 15,231 12,900 12,453 12,547
Return On Investment (TTM) 8.32 % 8.38 % 8.53 % 8.3 % 8.13 %
DGX's Overall Ranking # 1016 # 1192 # 961 # 960 # 998
Seq. Investment Change TTM 5.5 % 5.39 % -0 % -0.11 % -0.04 %
Seq. Net Income Change TTM 4.76 % 3.53 % 2.77 % 1.95 % 2.19 %
Net Income (TTM) in Millions 1,166 1,113 1,075 1,046 1,026

DGX Company Profile >> Back to DGX Roi Comparisons >> See Annual DGX Return On Investment



Return On Investment DGX's Ranking
Within: No.
Industry # 3
Sector # 62
Overall # 1016

Return On Investment Statistics
High Average Low
18.8 %
9.49 %
5.1 %
(Jun 30 2021)   (March 31, 2008)







Financial Statements
Quest Diagnostics Inc's III. Quarter Investments $ 15,468 Millions DGX's Balance sheet
Quest Diagnostics Inc's III. Quarter Income $ 312 Millions Quarterly DGX's Income Statement
DGX's Income by Division See DGX's Income by Division


DGX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 12,453 12,511 10,828 9,985 11,937
Y / Y Investment Growth -0.46 % 15.54 % 8.44 % -16.35 % -3.2 %
Net Income in Millions 1,046 921 908 1,015 2,080
Y / Y Net Income Growth 13.57 % 1.43 % -10.54 % -51.2 % 38.76 %
Annual Return On Investment 8.4 % 7.36 % 8.39 % 10.17 % 17.42 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 8.4 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DGX's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DGX's Competitors
Subscribers only: Roi for Quest Diagnostics Inc's Suppliers
Subscribers only: Return On Investment for DGX's Customers

Other Ratios
DGX's Roa DGX's Inventory Turnover Ratio DGX's Growth Rates DGX's Dividend Statistics
DGX's Profitability Ratios DGX's Asset Turnover Ratio DGX's Dividend Growth
DGX's Roe DGX's Valuation Ratios DGX's Financial Strength Ratios DGX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %

Date modified: 2026-10-24T15:37:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.